Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BHV-8000 in Early Parkinson's Disease
NCT06976268Phase 3Recruiting
- Sponsor
- Biohaven Ltd.
- Start
- May 2025
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
A Phase 3 trial of BHV-8000 in Parkinson's disease (PD), sponsored by Biohaven Ltd.. Started May 2025; status: recruiting.
02
Drugs
BHV-8000
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT06976268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06976268.